Australia's Clarity Pharmaceuticals plunges as full year loss widens

Clarity Pharmaceuticals

28/08/2025 06:38

** Shares of Clarity Pharmaceuticals  CU6.AX fall as much as 5.8% to A$3.240, their lowest level since July 16

** Co posts preliminary FY25 loss of A$64.3 million($41.78 million), wider than A$42 million loss posted in pcp

** Meanwhile, the benchmark S&P/ASX 200 .AXJO is up 0.1%

** CU6 down 22.3% YTD, including current session

($1 = 1.5389 Australian dollars)

 (Reporting by Nichiket Sunil in Bengaluru)

 ((Nichiket.Sunil@thomsonreuters.com))